Similar articles

• Observations on the role of endotoxin in graft-versus-host disease.

  Lampert IA, Moore RH, Huby R, Cohen J. Lampert IA, et al. Prog Clin Biol Res. 1988;272:351-9. Prog Clin Biol Res. 1988. PMID: 3293081
• Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

  Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ. Asai O, et al. J Clin Invest. 1998 May 1;101(9):1835-42. doi: 10.1172/JCI1268. J Clin Invest. 1998. PMID: 9576746 Free PMC article.
• [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].

  Li Y, Guo K, Chen Y, Song Z, Li J, Deng L. Li Y, et al. Zhonghua Xue Ye Xue Za Zhi. 2002 Aug;23(8):411-4. Zhonghua Xue Ye Xue Za Zhi. 2002. PMID: 12411044 Chinese.
• Acute graft-versus-host disease after allogeneic bone marrow transplantation.

  Perreault C, Gyger M, Boileau J, Bonny Y, Cousineau S, Lacombe M, Lavallee R, Tawil E, D'Angelo G. Perreault C, et al. Can Med Assoc J. 1983 Nov 1;129(9):969-74. Can Med Assoc J. 1983. PMID: 6367917 Free PMC article. Review.
• [PBSCT and GVHD].

  Hino M, Yamane T, Ohta K, Tatsumi N. Hino M, et al. Rinsho Byori. 1999 May;Suppl 110:92-8. Rinsho Byori. 1999. PMID: 10475037 Review. Japanese.